Stay updated on Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Sign up to get notified when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.

Latest updates to the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page
- Check5 days agoChange DetectedVisual/UI changes are present (layout and styling adjustments) while core study details remain unchanged (eligibility criteria, outcomes, locations, etc.). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and updated the page revision to v3.3.2. The older PubMed wording was replaced.SummaryDifference0.2%

- Check28 days agoChange DetectedRemoved the site-wide notice about government funding and NIH operating status from the page; this is a non-core notification and does not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check35 days agoChange DetectedNo significant changes detected between the old and new screenshots; the page content and key details appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe changes appear to be minor UI/layout updates with no impact on core study information such as eligibility and outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedNo significant changes detected. The page remains as before; no additions or deletions to core content, names, prices, stock, or time-sensitive details were identified.SummaryDifference0.6%

Stay in the know with updates to Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral QLT091001 in LCA/RP Due to RPE65/LRAT Mutations Clinical Trial page.